| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/20/2003 | CA2484607A1 Methods and compositions for inducing an immune response |
| 11/20/2003 | CA2484266A1 Cancer vaccines and methods of using the same |
| 11/20/2003 | CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis |
| 11/20/2003 | CA2484001A1 Methods for increasing oil content in plants |
| 11/20/2003 | CA2483997A1 A modified yeast consuming l-arabinose |
| 11/20/2003 | CA2483930A1 Methods for the enrichment of low-abundance polynucleotides |
| 11/20/2003 | CA2483698A1 Cytokine polypeptides |
| 11/20/2003 | CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 11/20/2003 | CA2460679A1 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 11/19/2003 | EP1362928A2 Genotyping by amplicon melting curve analysis |
| 11/19/2003 | EP1362918A1 Gene transfer methods |
| 11/19/2003 | EP1362917A2 A fusion protein for use as vector |
| 11/19/2003 | EP1362916A2 Human tumor necrosis factor delta and epsilon |
| 11/19/2003 | EP1362915A1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
| 11/19/2003 | EP1362914A2 Histone deacetylase inhibitor and use thereof |
| 11/19/2003 | EP1362913A2 Interaction trap system for isolating proteins |
| 11/19/2003 | EP1362912A1 Method of amplifying mrna and cdna in microquantities |
| 11/19/2003 | EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 11/19/2003 | EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R) |
| 11/19/2003 | EP1362867A2 Control of the ratio of LAP to LIP |
| 11/19/2003 | EP1362866A1 Use of the repressor glxR for the synthesis of lysine in Corynebacterium glutamicum |
| 11/19/2003 | EP1362600A1 Pharmaceutical compositions containing decoy and method of using the same |
| 11/19/2003 | EP1362597A1 Antigenic peptides derived from telomerase |
| 11/19/2003 | EP1362596A2 Inhibitor of stem cell proliferation and uses thereof |
| 11/19/2003 | EP1362510A2 A mouse model for hepatocellular carcinoma by targeted integration of hepatitis B virus genes |
| 11/19/2003 | EP1362235A2 Peptide or protein microassay method and apparatus |
| 11/19/2003 | EP1362125A2 Method for identifying biologically active structures of microbial pathogens |
| 11/19/2003 | EP1362124A1 Methods and probes for the detection of cancer |
| 11/19/2003 | EP1362122A2 Microarrayed organization of transcription factor target genes |
| 11/19/2003 | EP1362121A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 11/19/2003 | EP1362120A1 Method for purification of soluble ssao |
| 11/19/2003 | EP1362114A2 Replicative in vivo gene targeting |
| 11/19/2003 | EP1362113A2 Constitutive promoter from arabidopsis |
| 11/19/2003 | EP1362112A2 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
| 11/19/2003 | EP1362111A2 Regulatory genes suitable for use in gene expression |
| 11/19/2003 | EP1362110A1 Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule |
| 11/19/2003 | EP1362109A2 Recombinant oligomeric protein complexes with enhanced immunogenic potential |
| 11/19/2003 | EP1362108A2 Novel human protease and polynucleotides encoding the same |
| 11/19/2003 | EP1362107A2 Human phospholipase b-like polypeptide and uses thereof |
| 11/19/2003 | EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 11/19/2003 | EP1362105A2 Anti-interferon-alpha antibodies |
| 11/19/2003 | EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 11/19/2003 | EP1362103A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 11/19/2003 | EP1362102A1 Pg-3 and biallelic markers thereof |
| 11/19/2003 | EP1362101A2 Orientation-directed construction of plasmids |
| 11/19/2003 | EP1362097A2 Champ-a cardiac helicase-like factor |
| 11/19/2003 | EP1362096A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 11/19/2003 | EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 11/19/2003 | EP1362093A1 Rapid production of monoclonal antibodies |
| 11/19/2003 | EP1362062A1 Concatameric immunoadhesion |
| 11/19/2003 | EP1362059A2 Method for identifying herbicidally active substances |
| 11/19/2003 | EP1362058A2 Comparative ligand mapping from mhc positive cells |
| 11/19/2003 | EP1361896A2 Localized myocardial injection method for treating ischemic myocardium |
| 11/19/2003 | EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 11/19/2003 | EP1361892A1 Binding domain-immunoglobulin fusion proteins |
| 11/19/2003 | EP1361794A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 11/19/2003 | EP1361789A2 Method for embryo transfer after impregnation of the recipient female |
| 11/19/2003 | EP1361788A2 Primordial germ cell-based germ line production of birds |
| 11/19/2003 | EP1208160B1 Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use |
| 11/19/2003 | EP1047446B1 Vaccine composition for herpes simplex virus and methods of using |
| 11/19/2003 | EP1011723B1 88kda tumorigenic growth factor and antagonists |
| 11/19/2003 | EP0934425B1 Renilla luciferase and green fluorescent protein fusion genes |
| 11/19/2003 | EP0884052B1 Cartilage/bone inducing materials for reparation |
| 11/19/2003 | EP0760859B1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines |
| 11/19/2003 | EP0733066B1 Pretargeting methods and compounds |
| 11/19/2003 | EP0724634B1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
| 11/19/2003 | EP0665890B1 Increased production of secreted proteins by recombinant eukaryotic cells |
| 11/19/2003 | EP0640137B1 Immortalized human cell lines containing exogenous cytochrome p450 genes |
| 11/19/2003 | EP0540573B2 Assay of free and complexed prostate-specific antigen (psa) |
| 11/19/2003 | CN1457366A Method to detect modulators of VEGF kinase domain |
| 11/19/2003 | CN1457365A Method for L-threonine production |
| 11/19/2003 | CN1457364A Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular PHA depolymerase |
| 11/19/2003 | CN1457363A Hypersensitive response eliciting domains of bacterial harpin and use thereof |
| 11/19/2003 | CN1457361A Method and system of disposing food wastes |
| 11/19/2003 | CN1456672A Glyphosate tolerance-5-enolpyruvoyl shikimic acid-3-phosphoric acid synthesizing enzyme and its coding genes |
| 11/19/2003 | CN1456671A Nucleotide series of shaogengen mould delta-6 fatty acid dehydrogenase and its use |
| 11/19/2003 | CN1456670A Genes of resveratrol stilbene synthase in parthenocissus and their use |
| 11/19/2003 | CN1456669A Method for producing human insulin by transgene romaine lettuce, tomato and tobaco |
| 11/19/2003 | CN1456665A Production of organic phosphorous chemicals decomposing enzyme by silkworm bioreactor |
| 11/19/2003 | CN1456664A Reorganized human glycogen phosphorylase isoenzyme BB and preparation thereof by methanal yeast and use thereof |
| 11/19/2003 | CN1456662A Barm expressing system of plasminogen and purifying process |
| 11/19/2003 | CN1456573A Nacre substrate protein, coding gene and cloning method and application thereof |
| 11/19/2003 | CN1456540A High-performance composite biological nuisanceless granular fertilizer and producing method thereof |
| 11/19/2003 | CN1128222C Novel secretion expression vector and its application of recombinant hirudin expression technology |
| 11/19/2003 | CN1128221C Gene encoding alkaline liquefying alpha-amylase |
| 11/19/2003 | CN1128209C Locust, microsporidian and East-Asia migratory locust strain product and its preparing process |
| 11/18/2003 | US6649814 Cytochrome P450 monooxygenases |
| 11/18/2003 | US6649813 Induction of resistance to virus diseases by transformation of plants with a plant virus replicase gene |
| 11/18/2003 | US6649812 Transforming a explant from sunflower, culturing, removing newly formed buds; eliminates callus formation stage; inserting nucleotide sequence that confers antibiotic resistance |
| 11/18/2003 | US6649811 Use of nimesulide for the preparation of a pharmaceutical formulation for treating a neurodegenerative condition |
| 11/18/2003 | US6649782 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
| 11/18/2003 | US6649769 For labelling a polynucleotides |
| 11/18/2003 | US6649751 Reacting biopolymers with alkylamines and ammonium hydroxide, heating and eluting through columns having ion exchange resins, then recovering the polynuleotides; solid phase synthesis |
| 11/18/2003 | US6649749 Oligonuclelotide mix for use in the detection and treatment of viral diseases |
| 11/18/2003 | US6649748 Peroxidase genomic gene derived from ipomoea batatas and a promoter thereof |
| 11/18/2003 | US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease |
| 11/18/2003 | US6649739 Protein, its gene, reagents for inducing apoptosis, and anticancer agent |
| 11/18/2003 | US6649738 Pancreas-derived plasminogen activator inhibitor |
| 11/18/2003 | US6649737 Human galactosyltranferases |
| 11/18/2003 | US6649596 Modified VEGF Oligonucleotides for Inhibition of tumor growth |